The legacy of Viagra and the pharmaceutical industry presents a challenging picture for careful investors. Initially, copyright's remarkable drug altered the treatment of erectile dysfunction, creating massive profits and defining the contemporary pharmaceutical landscape. However, exclusive rights expiration and the rise of generic versions have c